Morphology of Chronic Complications of Diabetes

Slide 1 · Morphology of Chronic

Complications of Diabetes

Pancreas · vasculature · kidney · eye · nervous system

Dr Abu Suraih Sakhri

MBBS, MD (Pathology)

www.abusuraihsakhri.com

Slide 2 · Learning objectives

Distinguish the structural lesions of diabetic macroangiopathy and microangiopathy.

Recognize the pancreatic changes characteristic of type 1 and type 2 diabetes.

Describe the glomerular, vascular and infectious components of diabetic renal pathology.

Link retinal, lens and neural complications to their morphologic basis.

Slide 3 · Chronic complications: Anatomic map

Affected site

Characteristic lesion

Functional consequence

Large and medium arteries

Accelerated atherosclerosis

Ischemic myocardial, cerebral and limb injury

Capillaries / microvessels

Diffuse basement-membrane thickening

Nephropathy, retinopathy, some neuropathies

Kidney

Glomerulosclerosis, arteriolosclerosis, pyelonephritis

Progressive loss of renal function

Pancreatic islets

Insulitis / islet loss or amyloid deposition

Corresponding islet dysfunction

Slide 4 · Diabetic tissue injury affects both major types

Chronic morphologic complications arise in both type 1 and type 2 diabetes.

Some pancreatic islet changes are more distinctive for a particular diabetes type.

Systemic consequences reflect vascular injury affecting multiple organs.

Distribution and severity depend on long-standing metabolic and vascular stress.

Slide 5 · Macrovascular versus microvascular disease

Dimension

Macrovascular

Microvascular

Principal level

Aorta; Large and medium muscular arteries

Capillaries and other small vessels

Signature lesion

Atherosclerotic plaque

Thickened basement membranes

Major organs

Heart, brain, lower limbs, renal arteries

Glomeruli, retina, peripheral nerves

Important distinction

Plaque morphology resembles ordinary atherosclerosis

Thick basement membranes remain abnormally permeable

Slide 6 · Persistent hyperglycemia connects metabolism to structure

Chronic

Hyperglycemia

AGE–RAGE /

PKC / polyol pathways

Inflammatory and

Oxidative stress

Matrix accumulation

And endothelial damage

Other influences include insulin resistance and associated cardiometabolic abnormalities.

Slide 7 · AGE-related vascular remodeling

Advanced glycation end products (AGEs) accumulate more rapidly in hyperglycemia.

AGE interaction with RAGE promotes inflammatory and vascular cell responses.

TGF-β-associated signaling increases deposition of basement-membrane material.

VEGF-associated responses are relevant to retinal vascular injury.

Slide 8 · Protein kinase C signaling in diabetic angiopathy

High intracellular

Glucose

DAG accumulation

And PKC activation

VEGF, TGF-β

And PAI-1 expression

Microvascular injury

And matrix change

AGE and PKC pathways have overlapping downstream effects.

Slide 9 · Polyol pathway and oxidative stress

Aldose reductase converts excess intracellular glucose to sorbitol.

This reaction consumes NADPH, needed to regenerate reduced glutathione.

Impaired antioxidant defenses increase susceptibility to oxidative stress.

Sorbitol accumulation contributes to diabetes-associated lens opacity.

Slide 10 · Metabolic mechanisms relevant to morphology

Mechanism

Immediate cellular effect

Morphologic implication

AGE formation / RAGE

Inflammation, growth-factor release

Microvascular matrix thickening

Excess PKC activity

VEGF, TGF-β and PAI-1 signaling

Endothelial and matrix responses

Polyol pathway

NADPH consumption; Oxidative stress

Cellular injury; Lens cataract

Hexosamine pathway

Abnormal metabolic flux

Proposed vascular and metabolic injury

Slide 11 · Pancreatic islets: Lesions to recognize

Setting

Dominant pancreatic morphology

Type 1 diabetes

Reduced islet number/size; T-cell-rich insulitis may be present

Type 2 diabetes

Subtle islet-cell loss; Islet amyloid deposition and occasional fibrosis

Infants of diabetic mothers

Increased number and size of pancreatic islets

Normal aging

Islet amyloid may also be found without diabetes

Slide 12 · Type 1 diabetes: Islet loss

Reduction in islet number and size is common, especially in rapidly progressive type 1 diabetes.

Residual islets may be small and difficult to identify.

Loss of endocrine parenchyma reflects the autoimmune β-cell destructive process.

Islet depletion is not expected to appear identically at every disease stage.

Slide 13 · Insulitis: Cellular composition

Insulitis consists predominantly of T lymphocytes infiltrating pancreatic islets.

The source notes that lymphocytic infiltrates may be found at clinical presentation.

Insulitis reflects immune-mediated islet damage rather than amyloid deposition.

The inflammatory infiltrate is a separate lesion from amyloid deposition in type 2 diabetes.

Slide 14 · Pancreatic islets: Source-grounded schematic

Type 1 diabetes

Type 2 diabetes

Islet loss and lymphocytic insulitis

Islet amyloid; Possible fibrosis

Schematic — original editable PowerPoint drawing

Slide 15 · Type 2 diabetes: Subtle loss of islet cells

A modest decrease in islet cell mass may occur in type 2 diabetes.

The decrease can be too subtle for routine morphologic assessment.

Morphometric studies may be required to demonstrate the reduction.

In contrast to type 1 diabetes, prominent insulitis is not a defining lesion.

Slide 16 · Islet amyloid in type 2 diabetes

Amyloid initially appears around islet capillaries and between endocrine cells.

With progression, deposits can replace much of the islet parenchyma.

Advanced islets may become nearly obliterated by amyloid.

Islet fibrosis may accompany these changes.

Slide 17 · Islet amyloid: Spatial progression

Pericapillary

Deposition

Intercellular

Amyloid expansion

Loss of viable islet

Architecture

Marked islet

Obliteration

This schematic shows the described morphologic distribution, not a quantified time course.

Slide 18 · Islet amyloid is not unique to diabetes

Amyloid deposits can be encountered in older people without diabetes.

Their presence therefore requires clinicopathologic interpretation.

A small amyloid deposit is not equivalent to complete islet loss.

The important teaching distinction is extent and setting, not amyloid alone.

Slide 19 · Type 1 versus type 2: Pancreatic morphology

Feature

Type 1

Type 2

Islet number/size

Often conspicuously reduced

May be subtly reduced

Inflammatory infiltrate

T-lymphocytic insulitis may be seen

Not the characteristic lesion

Amyloid

Not the distinguishing finding

Often deposited within islets

Fibrosis

Not emphasized as a defining lesion

Can accompany advanced amyloid

Slide 20 · Fetal islet response in diabetic pregnancy

Islet number and size can increase in newborns of mothers with diabetes.

Maternal hyperglycemia stimulates the fetal endocrine pancreatic response.

This observation concerns the infant pancreas, not chronic adult diabetic microangiopathy.

It illustrates how one metabolic exposure can yield different morphology by developmental context.

Slide 21 · Macroangiopathy: Accelerated atherosclerosis

The hallmark is accelerated atherosclerosis in the aorta and large and medium arteries.

Persistent hyperglycemia and insulin resistance contribute to endothelial dysfunction.

The microscopic architecture of plaques is not distinct from nondiabetic atherosclerosis.

Greater plaque burden raises the risk of major ischemic complications.

Slide 22 · Atherosclerosis: Morphology versus burden

Conventional plaque morphology

Accelerated occurrence in diabetes

Atherosclerotic intimal plaque

Greater plaque burden → ischemia

Schematic — original editable PowerPoint drawing

Slide 23 · Endothelial dysfunction precedes ischemic outcomes

Metabolic injury affects the vascular endothelium throughout the circulation.

Endothelial dysfunction creates a milieu favoring atherogenesis.

Large-vessel lesions then produce organ-specific ischemic events.

Plaque appearance alone cannot reliably identify whether a patient has diabetes.

Slide 24 · Coronary disease: Morphologic cause of myocardial infarction

Diabetic vascular

Endothelial injury

Accelerated coronary

Atherosclerosis

Coronary blood-flow

Restriction / occlusion

Ischemic myocardial

Necrosis

Myocardial infarction is emphasized as the commonest cause of death section.

Slide 25 · Peripheral arterial disease and gangrene

Advanced atherosclerotic narrowing compromises perfusion of the lower limbs.

Critical ischemia can progress to tissue necrosis and gangrene.

Coexisting neuropathy and susceptibility to infection worsen limb complications.

Gangrene is a tissue endpoint, not a specific histologic form of diabetic vasculopathy.

Slide 26 · Diabetes also affects the cerebral circulation

Accelerated large-vessel disease can contribute to cerebral infarction.

The systemic complication map also includes cerebrovascular hemorrhage.

Hypertension and atherosclerosis modify the pattern of vascular injury.

These outcomes are consequences of vascular pathology, not primary islet lesions.

Slide 27 · Renal arteries versus intrarenal microcirculation

Vascular level

Morphologic effect

Renal importance

Large renal arteries

Atherosclerotic narrowing

May contribute to ischemic injury

Glomerular capillaries

GBM thickening, mesangial sclerosis

Major determinant of diabetic nephropathy

Afferent / efferent arterioles

Hyaline arteriolosclerosis

Additional reduction in perfusion

Interstitial vasculature

Microangiopathic change

Contributes to chronic renal damage

Slide 28 · Macrovascular lesions: Diagnostic interpretation

Atherosclerosis itself is not histologically specific for diabetes.

Clinical context establishes whether diabetes contributes to accelerated disease.

Vascular territories must be assessed according to the organ affected.

Renal dysfunction in diabetes may reflect far more than renal-artery plaque.

Slide 29 · Diabetic microangiopathy: Defining lesion

Diffuse basement-membrane thickening is among the most consistent microscopic findings.

The lesion is prominent in capillaries of several organs.

Some nonvascular basement membranes are also thickened.

Despite thickening, permeability to plasma proteins increases.

Slide 30 · Basement-membrane thickening is not protection

Normal capillary

Diabetic microangiopathy

Thin basement membrane

Thick basement membrane

With abnormal permeability

Schematic — original editable PowerPoint drawing

Slide 31 · Where basement membranes thicken

Capillary locations

Additional basement-membrane sites

Skin and skeletal muscle

Peripheral nerves

Retina

Renal tubules

Renal glomeruli

Bowman capsule

Renal medulla

Placenta

Slide 32 · Why a thicker capillary may still leak

Diabetic basement-membrane thickening is not equivalent to a normal functional barrier.

Capillaries remain abnormally permeable to plasma proteins.

Matrix accumulation and endothelial dysfunction coexist.

The morphologic lesion helps explain chronic microvascular organ damage.

Slide 33 · Microangiopathy gives rise to three major syndromes

Diffuse microvascular basement-membrane injury

Diabetic nephropathy

Diabetic retinopathy

Some diabetic neuropathies

Three parallel organ consequences of a shared microangiopathic process.

Slide 34 · Diabetic nephropathy: Three lesion families

Glomeruli

Renal vessels

Renal interstitium

GBM thickening

Atherosclerosis of renal arteries

Acute or chronic pyelonephritis

Diffuse mesangial sclerosis

Hyaline arteriolosclerosis

Papillary necrosis

Nodular glomerulosclerosis

Afferent and efferent injury

Tubular atrophy and fibrosis

Slide 35 · Diabetic nephropathy is not one lesion

Glomerular matrix injury is central to diabetic nephropathy.

Arterial and arteriolar disease create additional perfusion deficits.

Inflammatory infection-related injury can coexist in renal parenchyma.

The relative contribution of each compartment varies across kidneys.

Slide 36 · Renal tissue injury: A compartmental map

Glomerular matrix expansion

Arteriolar hyalinosis

Chronic renal ischemia

Tubular atrophy and interstitial fibrosis

Slide 37 · Glomerular basement-membrane thickening

The glomerular capillary basement membrane (GBM) thickens diffusely.

This is a major manifestation of diabetic microangiopathy.

Electron microscopy best demonstrates the increased GBM thickness.

Thickened GBM commonly accompanies mesangial expansion.

Slide 38 · GBM thickening: Early structural evolution

Sustained

Hyperglycemia

Expanded glomerular

Basement membrane

Mesangial

Widening

Progressive

Glomerular dysfunction

The source describes measurable GBM thickening early in type 1 diabetes.

Slide 39 · Electron microscopy: What is assessed

Measure or evaluate thickening of the glomerular capillary basement membrane.

Interpret the capillary lumen, basement membrane and urinary space in correct orientation.

Conventional light microscopy may not show early ultrastructural change adequately.

Early ultrastructural change can precede advanced nodular glomerulosclerosis.

Slide 40 · Tubular basement membranes are also thickened

Progressive GBM change is accompanied by thickening of tubular basement membranes.

Both glomerular and tubular compartments are affected by the diabetic process.

PAS highlights basement-membrane material on renal tissue sections.

Tubular involvement should be considered in addition to the glomerular lesions.

Slide 41 · Diffuse mesangial sclerosis: Defining feature

There is a diffuse increase in mesangial matrix throughout affected glomeruli.

Expanded mesangial areas stain positively with periodic acid–Schiff (PAS).

The lesion reduces the proportion of normal patent capillary architecture.

Diffuse mesangial expansion correlates with worsening renal function.

Slide 42 · Diffuse versus nodular mesangial matrix

Diffuse mesangial sclerosis

Nodular glomerulosclerosis

PAS-positive expanded mesangial matrix

Ovoid PAS-positive mesangial nodule

Schematic — original editable PowerPoint drawing

Slide 43 · PAS stain highlights renal matrix lesions

PAS positivity brings basement-membrane and mesangial matrix material into relief.

Diffuse mesangial sclerosis increases matrix across the tuft.

Nodules are also PAS-positive but localized to mesangial regions.

The stain demonstrates morphology; A diagnosis requires contextual interpretation.

Slide 44 · Mesangial expansion and proteinuria

Diffuse mesangial

Matrix accumulation

Distortion of glomerular

Capillary architecture

Progressively impaired

Filtration barrier

Increasing urinary

Protein excretion

The source associates mesangial expansion with increasing proteinuria.

Slide 45 · From diffuse matrix increase to nodules

With disease progression, mesangial matrix deposits can become nodular.

The background glomerulus often retains diffuse sclerosis.

Nodularity is superimposed on, rather than a replacement for, diffuse injury.

Not every glomerular lobule is affected by a nodule to the same degree.

Slide 46 · Kimmelstiel–Wilson nodules

Nodular glomerulosclerosis is also called intercapillary glomerulosclerosis.

It is characterized by ovoid or spherical, often laminated, PAS-positive mesangial nodules.

Nodules are commonly situated at the periphery of glomerular lobules.

Adjacent glomerular capillary loops may remain patent or become markedly dilated.

Slide 47 · Where the nodules sit

Nodules lie within the mesangial cores of affected glomerular lobules.

They must be distinguished spatially from the peripheral capillary lumina.

Some lobules may show striking nodular change while others remain diffusely sclerotic.

Appreciating this distribution is essential for recognizing nodular mesangial sclerosis.

Slide 48 · Mesangiolysis and microaneurysm formation

Mesangiolysis disrupts anchoring interactions between mesangial stalks and capillaries.

Loss of structural support can permit glomerular capillary microaneurysm formation.

The nodules may therefore coexist with dilated peripheral capillary loops.

This mechanism links altered mesangial structure with capillary geometry.

Slide 49 · How mesangiolysis changes a capillary loop

Disruption of

Mesangial anchoring

Reduced support of

Capillary loops

Loop expansion

And dilation

Glomerular capillary

Microaneurysm

Mechanism describes a structural possibility, not a mandatory feature of every nodule.

Slide 50 · Fibrin caps and capsular drops

Hyaline deposits can accumulate within glomerular capillary loops (“fibrin caps”).

Other deposits adhere to the Bowman capsule (“capsular drops”).

These lesions may accompany nodular glomerulosclerosis.

The terms describe their histologic location, not separate kidney diseases.

Slide 51 · Hyaline change can affect both glomerular arterioles

Afferent arteriole

Efferent arteriole

Hyaline wall thickening narrows the lumen

Efferent hyalinosis is especially suggestive of diabetes

Schematic — original editable PowerPoint drawing

Slide 52 · Afferent and efferent arteriolar hyalinosis

Diabetic renal hyaline arteriolosclerosis affects afferent as well as efferent arterioles.

Efferent-arteriolar hyalinosis is particularly unusual outside diabetes.

Progressive hyaline deposition narrows arteriolar lumina.

The resulting ischemia adds to glomerular damage.

Slide 53 · Vascular and glomerular damage contract the kidney

Glomerulosclerosis

And arteriolar hyalinosis

Chronic renal

Ischemia

Tubular atrophy

Interstitial fibrosis

Reduced cortical

Thickness and renal size

The characteristic late morphology integrates multiple renal compartments.

Slide 54 · End-stage diabetic nephrosclerosis: Schematic

Relatively preserved cortex

Advanced diabetic nephrosclerosis

Broad cortical compartment

Thinned cortical compartment

Schematic — original editable PowerPoint drawing

Slide 55 · Gross nephrosclerosis in long-standing diabetes

Advanced diabetic kidneys may become contracted.

The renal surface can develop diffuse granular change.

Cortical tissue becomes markedly thinned.

Irregular scars can be superimposed when pyelonephritis is present.

Slide 56 · Renal morphology: Light microscopy to gross anatomy

Level

Signature finding

Interpretation

Electron microscopy

Thickened glomerular capillary basement membrane

Early microangiopathic change

Light microscopy / PAS

Diffuse mesangial matrix and/or nodules

Progressive glomerulosclerosis

Arterioles

Hyaline thickening; Afferent and efferent involvement

Compromised microvascular perfusion

Gross kidney

Granular surface, cortical thinning, contraction

Advanced chronic parenchymal scarring

Slide 57 · Pyelonephritis complicates diabetes

Both acute and chronic pyelonephritis are more frequent and severe in diabetes.

The process generally begins within the renal interstitium.

Inflammation can extend to and injure renal tubules.

Infection-related scarring may coexist with diabetic glomerulosclerosis.

Slide 58 · Papillary necrosis in diabetic pyelonephritis

Renal papillary necrosis is a particularly important complication of acute pyelonephritis.

The lesion reflects necrotizing injury to the renal papilla.

It is encountered more often in patients with diabetes than without diabetes.

It belongs to the infectious/necrotizing spectrum rather than glomerular nodular sclerosis.

Slide 59 · Glomerular injury versus pyelonephritis

Glomerulosclerosis

Pyelonephritis

Glomerulus and its capillary matrix are central.

Tubulointerstitial inflammation is central.

GBM thickening; PAS-positive mesangial matrix.

Inflammation can spread into tubules.

Diffuse or nodular sclerosis may develop.

Acute or chronic patterns; Papillary necrosis.

Associated with proteinuria and chronic kidney dysfunction.

Adds infection-related damage and scarring.

Slide 60 · Interpreting mixed diabetic renal disease

A kidney can show simultaneous glomerular, vascular and interstitial lesions.

An arteriolar lesion need not explain all observed glomerular injury.

Conversely, glomerular matrix disease need not explain every cortical scar.

A compartment-based description is more informative than a single undifferentiated label.

Slide 61 · Diabetic ocular complications: Three anatomic targets

Structure

Morphologic or anatomic change

Consequence

Lens

Acquired lens opacification

Cataract / blurred vision

Anterior chamber / optic nerve

Raised intraocular pressure; Optic-nerve damage

Glaucomatous visual impairment

Retinal microvasculature

Retinal vasculopathy; Possible neovascularization

Progressive retinopathy

Slide 62 · Cataracts: Loss of lens transparency

Diabetes-associated hyperglycemia promotes acquired lens opacification.

Sorbitol accumulation is one contributor described in the metabolic context.

A cataract is a structural optical complication rather than a retinal capillary lesion.

It should be differentiated anatomically from glaucoma and retinopathy.

Slide 63 · Glaucoma: Pressure-related optic-nerve injury

Long-standing diabetes is associated with increased risk of glaucoma.

Glaucoma involves elevated intraocular pressure and consequent optic-nerve damage.

The relevant structural injury is not an islet or glomerular lesion.

Visual loss in diabetes may arise by more than one ocular pathway.

Slide 64 · Background versus proliferative retinopathy

Background / preproliferative

Proliferative

Retinal vascular injury without defining new-vessel proliferation.

New-vessel growth becomes the prominent distinguishing feature.

Reflects chronic diabetic retinal microangiopathy.

Can be driven by hypoxia-induced VEGF expression.

Potential for progression remains.

Fragile new vessels threaten visual function.

Slide 65 · Retinal hypoxia to neovascularization

Diabetic retinal

Vasculopathy

Retinal perfusion

Insufficiency

Hypoxia-driven

VEGF signaling

Pathologic retinal

Neovascularization

This mechanistic context is stated in the neighboring Robbins clinical-complications section.

Slide 66 · Peripheral nerves: Another microvascular target

Diabetic neuropathy is common, particularly in long-standing diabetes.

The source identifies peripheral nerves among sites of basement-membrane thickening.

Some neuropathic injury is associated with diabetic microangiopathy.

The nervous-system phenotype is elaborated in the neighboring clinical section.

Slide 67 · Diabetic neuropathy: Clinical-anatomic patterns

Distal symmetric sensorimotor neuropathy commonly begins in the lower limbs.

More advanced disease may produce a stocking-and-glove distribution.

Autonomic neuropathy can disturb visceral function.

Some patients develop focal mononeuropathies, including cranial-nerve palsies.

Slide 68 · Neuropathy, ischemia and infected foot lesions

Neuropathy → unrecognized injury

Peripheral arterial insufficiency

Impaired wound defense

Infection, tissue necrosis and gangrene

Slide 69 · Application: Recognize a diabetic glomerular pattern

A long-standing diabetic patient has proteinuria. Renal histology shows diffuse PAS-positive mesangial expansion, rounded peripheral mesangial nodules, and hyaline change in both glomerular arterioles.

Which three morphologic lesions should be named?

Slide 70 · Application: Renal pattern — interpretation

The glomerulus contains diffuse mesangial sclerosis and nodular (Kimmelstiel–Wilson) sclerosis. Both afferent and efferent arterioles exhibit hyalinosis.

Morphologic synthesis: Diabetic glomerulosclerosis with arteriolar hyalinosis.

Slide 71 · Application: Distinguish tissue compartments

A kidney from a patient with diabetes has nodular glomerular sclerosis together with cortical depressions attributed to previous pyelonephritis.

Are these two morphologic findings synonymous?

Slide 72 · Application: Separate coexisting renal lesions

Nodular matrix expansion belongs to glomerulosclerosis. Irregular pyelonephritic scarring reflects a tubulointerstitial inflammatory process. Both can coexist.

Answer: Separate lesions in distinct renal compartments.

Slide 73 · Application: Ocular mechanism

A diabetic patient develops retinal vascular complications with abnormal new-vessel growth. The associated vascular response is linked to retinal ischemia.

Which named growth factor connects retinal hypoxia to neovascularization?

Slide 74 · Application: Ocular mechanism — answer

Retinal ischemia leads to hypoxia-induced VEGF signaling. VEGF is implicated in the development of proliferative retinal neovascularization.

Answer: Vascular endothelial growth factor (VEGF).

Slide 75 · Integrating the morphologic phenotypes

Anatomic system

Dominant structural change

High-value recognition cue

Pancreatic islet

Insulitis / islet depletion / amyloid

Differentiate type 1 from type 2 patterns

Large vessels

Accelerated atherosclerosis

Plaque morphology itself is not unique

Microvasculature

Diffuse basement-membrane thickening

A thick wall can still be leaky

Kidney

Diffuse / nodular mesangial sclerosis

Kimmelstiel–Wilson nodule and efferent hyalinosis

Eye / nerves

Retinal neovascular response; Neural damage

Organ-specific consequences of chronic injury

Slide 76 · Core morphology to retain

Macroangiopathy is accelerated ordinary atherosclerosis; Microangiopathy is basement-membrane thickening with dysfunction.

The renal hallmark combines GBM thickening, diffuse mesangial sclerosis and sometimes Kimmelstiel–Wilson nodules.

Efferent as well as afferent arteriolar hyalinosis is an important diabetic renal clue.

Infectious papillary necrosis, retinal neovascularization, lens opacity and neuropathy involve distinct compartments.

Slide 77 · Principal source and figure provenance

Robbins, Cotran & Kumar: Pathologic Basis of Disease

11th edition (2026), The Endocrine System, chronic diabetic complications section.

Course diagrams are original PowerPoint schematics, not clinical or histologic specimens.

Source figures 24.34–24.39 were used as conceptual references only; their original artwork was not reproduced.